1492317211

Folia Neuropathol. 1995;33(2):85-92. IF: brak

14.

Klimek A, Niewinowska-Rupf K.

[Basilar migraine: case report]

Neurol Neurochir Pol. 1993 Jul-Aug;27(4):595-7. Polish.

IF: brak

15.

Lukomski M, Klimek A.

[Electronystagmographic examination in patients with amyotrophic lateral sclerosis (ALS)]

Neurol Neurochir Pol. 1993 Jul-Aug;27(4):493-8. Polish.

IF: brak

16.

Klimek A, Stepień H, Szulc-Kuberska J, Pisarek H.

[Calcitonin level in cerebrospinal fluid of patients with amyotrophic lateral sclerosis]

Pol Tyg Lek. 1992 Apr 6-13;47( 14-15):310-1. Russian.

IF: brak

17.

Klimek A.

Orgasm—a new trigger factor of cluster headache?

Cephalalgia. 1990 Aug;10(4):205-6. .

18

Klimek A, Stepień H, Szulc-Kuberska J.

[Concentration of epidermal growth factor in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis]

Neurol Neurochir Pol. 1990 May-Aug;24(3-4): 157-63. Polish.

19.

Szulc-Kuberska J, Klimek A, Stepień H, Woszczak M.

[Clinical trial of the treatment of amyotrophic lateral sclerosis with bromocriptine]

Neurol Neurochir Pol. 1990 Jan-Apr;24( 1-2):37-41. Polish.

20.

Klimek A, Szulc-Kuberska J. Stepień H.

|Effect of thyroliberin treatment on the thyrotropin and prolactin levels in patients w ith amyotrophic lateral sclerosis]

Neurol Neurochir Pol. 1990 Jan-Apr;24(l-2):31-6. Polish.

21.

Klimek A, Stepień H, Szulc-Kuberska J.

[THyroliberin test in patients with amyotrophic lateral sclerosis]

Pol Tyg Lek. 1989 Oct 23-Nov 6;44(43-45):918-20. Polish.

22.

Szulc-Kuberska J, Stepień H, Klimek A, Cieślak D.

Effect of bromocriptine and metoclopramide on serum prolactin levels in patients w ith amyotrophic lateral sclerosis.

J Neurol Neurosurg Psychiatry. 1988 May;51(5):643-5.

3

23.